Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
25.00
-0.25 (-0.99%)
Mar 24, 2026, 2:00 PM CST
Genomics BioSci & Tech. Market Cap
Genomics BioSci & Tech. has a market cap or net worth of 1.88 billion as of March 24, 2026. Its market cap has increased by 36.13% in one year.
Market Cap
1.88B
Enterprise Value
2.41B
Revenue
607.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.00
Market Cap Chart
Since December 16, 2013, Genomics BioSci & Tech.'s market cap has increased from 1.58B to 1.88B, an increase of 19.13%. That is a compound annual growth rate of 1.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 1.88B | 1.17% |
| Dec 31, 2025 | 1.86B | 33.85% |
| Dec 31, 2024 | 1.39B | -7.69% |
| Dec 29, 2023 | 1.51B | 19.84% |
| Dec 30, 2022 | 1.26B | 11.67% |
| Dec 30, 2021 | 1.13B | 0.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 2.29B |
| Sunny Pharmtech | 2.25B |
| Chunghwa Chemical Synthesis & Biotech | 2.23B |
| Anti-Microbial Savior BioteQ | 2.23B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.18B |
| TWi Biotechnology | 2.09B |
| Advagene Biopharma | 1.79B |
| TaiRx | 1.70B |